404P - Dose escalation study of vemurafenib with crizotinib or sorafenib in patient with BRAF-mutated advance cancers
| Autor: | Sakamuri, D. 1, Kato, S. 2, Huang, H.J. 3, Naing, A. 3, Holley, V.R. 3, Patel, S. 4, Piha-Paul, S.A. 3, Tsimberidou, A.M. 5, Hong, D.S. 6, Meric-Bernstam, F. 7, Janku, F. 3 |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v134-v134 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|